Holen Sie sich die Stockscreener-App
9.61
1.13%
-0.11
Handel nachbörslich:
9.60
-0.010
-0.10%
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
RSI Crosses Above 30 for Mind Medicine (MindMed) Inc. — Reversal in SightJuly 2025 News Drivers & Weekly Breakout Watchlists - sundaytimes.kr
1 Reason to Buy MindMed (MNMD) - AOL.com
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - MSN
MindMed Announces New Employee Inducement Grants - Business Wire
MindMed (MNMD) Q2 2025 Earnings Call Transcript - AOL.com
MindMed Reports Strong Q2 2025 Results - The Motley Fool
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer - MarketBeat
Using RSI to spot recovery in Mind Medicine (MindMed) Inc.Weekly Breakout Forecast with Entry Zones - Newser
What makes Mind Medicine (MindMed) Inc. stock price move sharplyFree Trade Ready Stock Watch for Short Term - Newser
MindMed Reports Strong Phase 3 Trial Progress and Leadership Appointment - The Globe and Mail
Pattern recognition hints at Mind Medicine (MindMed) Inc. upsideAlpha Generation Strategy with Low Volatility - Newser
Roth Capital Issues Pessimistic Outlook for MNMD Earnings - Defense World
What MACD signals say about Mind Medicine (MindMed) Inc.AI-Based Reversal Point Prediction Signal - Newser
What is HC Wainwright’s Forecast for MNMD FY2028 Earnings? - Defense World
Oppenheimer Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD) - Defense World
Is Mind Medicine stock a buy? - Cantech Letter
Mind Medicine upgraded at Oppenheimer on lead asset - MSN
A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $18 to $55 - 富途牛牛
Analysts Are Bullish on Top Healthcare Stocks: Mind Medicine (MNMD), Axsome Therapeutics (AXSM) - The Globe and Mail
Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
MindMed Bets Big On Psychedelic Therapies With Cash To Spare - Finimize
Mind Medicine stock upgraded at Oppenheimer (MNMD:NASDAQ) - Seeking Alpha
Mind Medicine's Promising Pipeline and Financial Stability Drive Buy Rating - AInvest
Mind Medicine resumed with an Outperform at Oppenheimer - TipRanks
Mind Medicine’s Promising Pipeline and Financial Stability Drive Buy Rating - TipRanks
Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's O - GuruFocus
Mind Medicine (MindMed)’s (MNMD) “Buy” Rating Reiterated at Chardan Capital - Defense World
What are the latest earnings results for Mind Medicine (MindMed) Inc.Invest confidently with advanced analysis tools - Jammu Links News
Why is Mind Medicine (MindMed) Inc. stock attracting strong analyst attentionFree Trading Psychology Coaching - Jammu Links News
How does Mind Medicine (MindMed) Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Mind Medicine (MindMed) Inc. stockOutstanding capital returns - Jammu Links News
What analysts say about Mind Medicine (MindMed) Inc. stockAccelerate your capital gains today - Jammu Links News
Is it the right time to buy Mind Medicine (MindMed) Inc. stockHigh-yield portfolio picks - Jammu Links News
How does Mind Medicine (MindMed) Inc. generate profit in a changing economyAchieve rapid financial growth with smart picks - Jammu Links News
When is Mind Medicine (MindMed) Inc. stock expected to show significant growthAchieve breakthrough investment performance - Jammu Links News
How volatile is Mind Medicine (MindMed) Inc. stock compared to the marketAI Powered Signals For Consistent Profits - jammulinksnews.com
MindMed (MNMD) Q2 Net Loss Jumps 625% - The Globe and Mail
MindMed Reports Strong Q2 2025 Financial Results - The Globe and Mail
Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive - AInvest
Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials - AInvest
Earnings call transcript: MindMed Q2 2025 reveals cash runway into 2027 - Investing.com Canada
Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript - MarketBeat
Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance
Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... By GuruFocus - Investing.com Canada
Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
Mind Medicine Advances Phase III Trials for Anxiety and Depression Treatment, Appoints New CFO - AInvest
Real time social sentiment graph for Mind Medicine (MindMed) Inc.Market Downturn Defense Strategy Analysis - Newser
MindMed August 2025 presentation slides: Phase 3 trials advance with $238M cash runway - Investing.com Nigeria
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):